Iron is essential for many biological functions including neurotransmitter synthesis, where the metal is a co-factor of tyrosine hydroxylase, which converts tyrosine to dopamine and further to norepinephrine. As the shared chemical structure, called catechol, may potentially bind iron we questioned whether tyrosine derived hormones would impact on cellular iron homeostasis in macrophages, which are central for the maintenance of body iron homeostasis. Using murine bone marrow-derived macrophages (BMDMs), we investigated the effect of catecholamines and found that only dopamine but neither tyrosine, nor norepinephrine, affected cellular iron homeostasis. Exposure of macrophages to dopamine increased the uptake of non-transferrin bound iron into cells. The expansion of intracellular iron upon dopamine treatment resulted in oxidative stress responses as evidenced by increased expression of nuclear factor erythroid 2-related factor (Nrf2) and hypoxia inducible factor-1a. As a consequence, the transcriptional expression of stress response genes such as heme oxygenase-1 and the iron export protein ferroportin1 were significantly increased. Genetic deletion of Nrf2 abolished these effects of dopamine. Dopamine directly affects cellular iron homeostasis by increasing iron incorporation into macrophages and subsequently promoting intracellular oxidative stress responses. Our observations are of interest for disorders involving dopamine and iron dyshomeostasis such as Parkinson's disease and restless legs syndrome, partly enlightening the underlying pathology or the therapeutic efficacy of dopamine agonists to overcome neuronal iron deficiency.
Introduction
Iron is essential for many biochemical and metabolic processes like mitochondrial respiration, oxidative phosphorylation, citric acid cycle, DNA synthesis or hormone production. Furthermore, iron is a central compound of the proteins hemoglobin and myoglobin, where it is involved in the reversible binding of oxygen [1, 2] .
A reduced availability of iron results in impaired oxygen consumption by the body, along with impaired metabolic activity, reduced mitochondrial functionality and a diminished cellular proliferation [3] [4] [5] [6] . On the other hand, excess iron can be detrimental as the metal catalyzes the formation of toxic hydroxyl radicals which cause cellular damage, apoptosis and organ failure over time [7] [8] [9] . Thus, a balanced orchestration of body iron homeostasis is essential to allocate a sufficient amount of the metal for metabolic functions and to avoid negative effects of iron deficiency or iron overload. Abbreviations: TfR1, transferrin receptor 1; Dmt1, divalent metal transporter 1; HIF-1a, hypoxia-inducible factor; IRP, iron regulatory protein; LIP, labile iron pool; FTH, ferritin heavy chain; FTL, ferritin light chain; Fpn1, ferroportin-1; Lcn2, lipocalin-2; 2, 5-DHBA, 2,5-dihydroxy benzoic acid; PD, Parkinson's disease; DOPA, dihydroxyphenylalanine; DA, dopamine; NE, norepinephrine; MAO, monoamine oxidase; ROS, reactive oxygen species; MAO-I, monoamine oxidase inhibitor; COMT, catechol-O-methyl-transferase; DRD, dopamine receptor; SLC, solute carrier; Nrf2, nuclear factor erythroid 2-related factor; HO-1, heme oxygenase-1; BMDMs, bone-marrow-derived macrophages; Wt, wild-type; PMs, peritoneal macrophages; DFO, deferoxamine; qRT-PCR, quantitative real-time PCR; HPRT, hypoxanthine phosphoribosyltransferase; NTBI, non-transferrin bound iron; TBI, transferrin bound iron; ARE, antioxidative responsive element; mnSOD, mitochondrial superoxide dismutase; Tyr-Hyd. Inh., tyrosine-hydroxylase inhibitor; NAC, Nacetylcysteine. ability to deliver approximately 90 to 95% of the body's daily needs of iron via re-utilization of the metal from senescent erythrocytes [1, 10] . In addition to that, macrophages can acquire iron by multiple other processes which include endocytosis mediated incorporation of transferrin bound iron via transferrin receptor 1 (TfR1), uptake of ferrous iron via divalent metal transporter 1 (Dmt1) or the import of iron via Zip14 [11] . The expression of TfR1 can be transcriptionally regulated by hypoxia-inducible factor (HIF-1a) and post-transcriptionally controlled via iron regulatory proteins (IRP) [12, 13] . Iron acquired by one of these multiple pathways can be incorporated into enzymes or immediately used for metabolic purposes. Intracellular iron can remain in low quantities in the labile iron pool (LIP), which reflects the metabolic available iron within the cell, or stored within ferritin, which consists of the subunits ferritin heavy chain (FTH) and light chain (FTL) [14] . The metal can be exported by ferroportin-1 (Fpn1), the only known iron exporter [15] . The orchestration of cellular iron uptake, utilization, storage and export is coordinated post-transcriptionally and translationally by IRP1 and IRP2 [1] . IRP1 and IRP2 are able to interact with RNA stem loop structures, termed iron responsive elements, which are located in 5 0 or 3 0 untranslated regions of mRNAs of central iron proteins like TfR1, ferritin and Fpn1 [16] .
Recent evidence suggested that mammalian cells can produce endogenous siderophores which shuttle iron within or across cells either by themselves or following interaction with a siderophore binding peptide such as lipocalin-2 (Lcn2) [17, 18] . Lcn2 is produced by several cells, including macrophages, in response to infections or ischemia-reperfusion injury [19, 20] . The mammalian siderophore 2,5-dihydroxy benzoic acid (2,5-DHBA) contains a catechol structure. Its isomer, 2,3-DHBA is highly common in bacterial siderophores as well [21] . Due to the fact that catechols bind iron and being aware of the potential interplay between iron and dopamine in Parkinson's disease (PD) [22] , we questioned whether catecholamines may affect cellular iron homeostasis.
Catecholamines are generated by conversion of the amino acid tyrosine by several enzymatic steps yielding subsequently L-dihydroxyphenylalanine (DOPA), dopamine (DA), norepinephrine (NE) and epinephrine. Catecholamines are mainly produced by cells of the central nervous system and the adrenal medulla but minute amounts can also be generated by alternatively activated macrophages [23] . Catecholamines exert multiple effects towards target cells and are inactivated by degrading enzymes such as monoamine oxidase (MAO) or catechol-O-methyl-transferase (COMT) [24, 25] . With the help of dopamine receptors (DRDs) catecholamines like DA can be incorporated into cells like neurons or macrophages [26] . In neurons DA can be transported via solute carrier (SLC) class 6 transport proteins [27] . Catecholamines like DA are known to induce reactive oxygen species (ROS) [28] . ROS are a major inducer of the multi-functional regulator nuclear factor erythroid 2-related factor (Nrf2). Nrf2 reduces oxidative stress, especially in mitochondria by trans-activation of down-stream effectors [29] . For instance, Nrf2 regulates important proteins of iron metabolism like Fpn1, FTH and the stress-responsive enzyme heme oxygenase-1 (HO-1) [30, 31] .
Herein we provide evidence that DA but neither NE nor tyrosine affect cellular iron homeostasis and transcellular iron trafficking, which may have important implications in diseases using dopamine as therapeutic agent such as PD or septicemia.
Methods

Cell isolation and culture
Bone marrow-derived macrophages (BMDMs) were harvested from wild-type (Wt), Lcn2 Tibiae and femurs were collected and flushed with cold PBS containing 1% penicillin-streptomycin. The BMDMs were cultured for 7 days in the presence of 50 ng/ml recombinant murine M-CSF (Preprotech, Vienna, Austria). Macrophages were incubated in DMEM and supplemented with either 5 mM L-tyrosine (SigmaAldrich, Vienna, Austria), 5 mM NE (Sigma-Aldrich, Vienna, Austria), 5 mM DA (Sigma-Aldrich, Vienna, Austria), 100 nM tranylcypromine (Sigma-Aldrich, Vienna, Austria), 0.5 mg/ml actinomycin D (Sigma-Aldrich, Vienna, Austria), ferric chloride (Sigma-Aldrich, Vienna, Austria), 1 mg/ml recombinant hepcidin (Peptanova, Sandhausen, Germany), deferoxamine (DFO) (Sigma-Aldrich, Vienna, Austria), 10 mM hemin (Sigma-Aldrich, Vienna, Austria), 10 mM N -acetylcysteine (Sigma-Aldrich, Vienna, Austria) or 10 mM of the HIF-1a-inhibitor PX-12 (Sigma-Aldrich, Vienna, Austria). Control samples were treated with solvent.
RNA extraction and quantitative real-time PCR (qRT-PCR)
Preparation of total RNA and quantification of mRNA expression by quantitative reverse transcription polymerase chain reaction were performed as previously described [20] . Hypoxanthine phosphoribosyltransferase (HPRT) was used as reference gene.
Western blot analysis
Protein extraction and Western blotting were carried out as described using a rabbit Fpn1 antibody (1:400; Eurogentec, Lìege, Belgium), a mouse anti-human TfR1 antibody (1:1000; Invitrogen), a rabbit anti-human ferritin antibody (1:500; Sigma-Aldrich), a rabbit anti HO-1 antibody (1:1000; Enzo), a rabbit IRP2 antibody (1:1000; Novus Biologicals), a rabbit HIF-1a antibody (1:1000; Cell Signaling), a rabbit Nrf2 antibody (1:1000 Abcam) and a rabbit actin antibody (1:1000; Sigma-Aldrich) as a loading control [32] .
Determination of iron uptake, release and intracellular iron
For macrophage iron import and export assays, cells were treated with DA, respectively solvent, and the iron import or export was determined by using 5 lM 59 Fe-citrate or 59 Fe-TBI exactly as previously described [33] . Intracellular iron concentrations were determined by atomic absorption spectrometry as described [34] .
Intracellular LIP measurement and determination of mitochondrial superoxide concentrations
The intracellular LIP value was determined as previously described [35] . Calcein-AM was purchased from Life technologies. To determine mitochondrial superoxide concentration, BMDMs were stained with MitoSOX (Invitrogen) [36] . Data were acquired on a Gallios (Beckman Coulter) flow cytometer.
Transcription factor assay
Nuclear protein extracts were prepared with the nuclear and cytoplasmic extraction reagent (Thermo Fisher Scientific). Nrf2-binding activity was measured with a commercially available transcription factor assay kit in exact accordance to the manufacturer's protocol (Active Motif).
Statistical analysis
Statistical analysis was performed using a SPSS statistical package. We determined significance by unpaired two-tailed Student's t test to assess data, when only two groups were compared. Analysis of variance (ANOVA) combined with Bonferroni's correction was used for all other experiments. Unless specified otherwise, data are depicted as lower quartile, median, and upper quartile (boxes) with minimum and maximum ranges or as means ± SD (bars). Generally, p-values < .05 were considered significant in any test.
Results
Dopamine but neither tyrosine nor norepinephrine affects iron homeostasis in macrophages
To study the potential effects of catecholamines on iron homeostasis, we examined the levels of TfR1, as its expression is controlled by intracellular iron levels in non-inflamed cells [1, 10] . We first investigated the effects of tyrosine, DA and NE at dosages between 50 nM and 50 lM towards the expression of TfR1 mRNA after 24 h of incubation. While neither tyrosine nor NE significantly altered TfR1 levels as compared to controls, we observed a dosedependent increase upon the addition of DA which was most pronounced in the presence of 5 lM DA (Fig. 1A-C) . Accordingly, we chose the dosage of 5 lM for the catecholamines in all subsequent experiments presented herein. Because catecholamines can be degraded by MAO, we repeated these experiments in the presence of the MAO-inhibitor (MAO-I) tranylcypromine resulting in an even more pronounced effect of DA towards the increase in TfR1 mRNA levels, whereas this treatment alone had no effect on TfR1 regulation by control cells (Fig. 1C) . Therefore, we added MAO-I to all experiments and described the group in future as DA stimulated. Furthermore, addition of a tyrosine-hydroxylase inhibitor, which increases the presence of endogenous tyrosine, didn't affect TfR1 mRNA levels either (data not shown).
To further scrutinize the effects of DA, we studied the expression of important genes for iron trafficking and utilization in a time dependent manner (Fig. 1D-F) . As compared to solvent treated cells, the addition of DA (always in the presence of MAO-I) resulted in a time dependent increase in TfR1 levels, which became significant after 24 h (Fig. 1D) . Of note, supplementation of BMDMs with DA caused a significant increase in Fpn1 mRNA levels starting even after 6 h of stimulation (Fig. 1E) . Similarly, DA treatment enhanced cytoplasmic mRNA levels of HO-1, the enzyme being responsible for heme degradation in macrophages and anti-oxidative responses, even after three hours with a maximum effect at 6 h (Fig. 1F) [37, 38] . To exclude an unspecific effect of DA and/or MAO-I, we studied cellular toxicity which showed no significant differences between control cells, DA + MAO-I or MAO-I treated cells (data not shown). The observed effects on mRNA expression translated into corresponding changes of protein expression (Fig. 1G) . To confirm that the observed effects of DA on the expression of iron genes were also present in other macrophages, we used PMs and found significant induction of Fpn1 levels by DA, which corresponded to the effects observed in BMDMs (data not shown).
To see whether DA-mediated regulation of Fpn1 expression occurs transcriptionally or at later regulatory steps, we treated BMDMs with the inhibitor of transcription actinomycin D followed by an immediate stimulation with DA or solvent for 8 h (Fig. 1H) . Actinomycin D treatment resulted in a complete inhibition of Fpn1 mRNA induction by DA, suggesting that DA affects Fpn1 expression by a transcriptional mechanism. Moreover, we also found that hepcidin-mediated degradation of Fpn1 was independent of DA. Addition of DA to BMDMs stimulated with recombinant hepcidin, which targets and degrades Fpn1 on the cell surface, didn't affect the degradation of Fpn1 by hepcidin (Fig. 1I) [15] .
Because DA is a catechol and bacterial catechol type siderophores such as enterobactin are bound by the mammalian protein Lcn2, we asked whether the effects of DA on macrophage iron homeostasis are Lcn2 dependent [17, 19, 39] . Using BMDMs from Wt and Lcn2
À/À mice we found that DA increased Fpn1, TfR1 and HO-1 mRNA expression in both genotypes in a comparable fashion, indicating that the effect of DA on iron homeostasis was independent of Lcn2 ( Fig. 1J ; data not shown).
To evaluate if DA-mediated altered expression of TfR1 and Fpn1 resulted in changes of transcellular iron fluxes, we evaluated the import and export of radiolabeled iron into cells. DA stimulation was associated with an increased (144,5%) incorporation of radiolabeled non-transferrin bound iron (NTBI) into cells (Fig. 1K) . Of note, neither the mRNA expression of the molecular transmembrane iron transporters Dmt1 nor Zip14 were altered by cellular treatment with DA for 24 h as compared to solvent treated controls (data not shown) [11] . The uptake of transferrin-bound iron (TBI), in contrast to the NTBI uptake, was not significantly affected (102,4%) by DA, which could be due to the minor alterations of TfR1 protein expression following DA treatment, although TfR1 mRNA increased slightly but significantly over time following DA stimulation (Fig. 1L) . However, while NTBI incorporation was significantly increased in DA treated cells, cellular iron export was significantly reduced (76%) in DA treated compared to control cells (Fig. 1M ).
Dopamine affects intracellular iron content in macrophages
Based on the contrasting effects of DA on cellular iron uptake and release, we examined the net impact of DA on cellular iron content. Of interest, DA treatment of macrophages for 24 h resulted in a significant increase in intracellular iron levels as measured by atomic absorption spectrometry, whereas no obvious change was observed after 6 h of DA stimulation ( Fig. 2A) . While, we found only slightly increased levels of the iron storage protein ferritin in DA stimulated cells performing Western blot analysis, the cellular levels of IRP2, which is known to be degraded by increased intracellular levels of metabolically active iron, were significantly decreased by DA treatment (Fig. 2B ) [1, 35, 40] . This assumption was confirmed by determination of the LIP using calcein quenching, indicating that DA treatment of BMDMs for 24 h resulted in increased amounts of metabolically active iron (Fig. 2C) .
To examine whether the increase in cellular iron content in DA treated macrophages may result in enhanced iron incorporation into ferritin as well, we studied the effects of DA in macrophages obtained from mice with macrophage-specific deletion of ferritin-H (FtH À/À ) and in controls. We observed no difference in the induction of Fpn1 and TfR1 mRNA expression by DA between the two genotypes, although TfR1 baseline expression was already slightly increased in FtH À/À macrophages as compared to control cells even in the absence of DA (Fig. 2D, E) . To evaluate the influence of HO-1 on DA-dependent induction of Fpn1 expression, we stimulated macrophages isolated from Wt and HO-1 À/À with DA or solvent for 24 h (Fig. 2F ). We observed a slightly decreased induction of Fpn1 mRNA expression by DA in HO-1 À/À macrophages as compared to Wt BMDMs. However, treatment of HO-1 À/À BMDMs with DA resulted in a significant increase in Fpn1 expression as compared to untreated macrophages, suggesting the presence of other DA inducible mechanisms being responsible for this observation (Fig. 2F) . Fig. 1 . Dopamine but neither tyrosine nor norepinephrine affects iron homeostasis in macrophages. BMDMs, isolated from Wt mice, were stimulated with 5 mM tyrosine (Tyr) (A), 5 mM norepinephrine (NE) (B) or solvent (Ctrl) for 24 h and TfR1 mRNA expression was determined by qRT-PCR. Wt BMDMs were treated with 5 mM DA, 100 nM of the monoamine-oxidase inhibitor tranylcypromine (MAO-I), with DA in the presence of MAO-I (DA + MAO-I) or solvent (Ctrl) for 24 h and analyzed for TfR1 expression (C). Data were normalized for mRNA levels of HPRT and relative changes to the solvent control were shown (n = 3 independent experiments). BMDMs isolated from Wt mice were stimulated with 5 mM DA or solvent (Ctrl) for 3 to 24 h. TfR1 (D), Fpn1 (E) and HO-1 (F) expression were determined by qRT-PCR, data were normalized for mRNA levels of HPRT and fold-changes relative to the solvent control (3h) are shown (n = 4 independent experiments). Statistically significant differences were calculated by ANOVA using Bonferroni's correction. Superscripts indicate statistical significance compared to the control of the corresponding time-point. Wt BMDMs were stimulated with DA for 24 h. Western blot analysis of whole cell lysates using specific antibodies to TfR1, Fpn1, HO-1 and the loading control b-actin (G) was performed. The quantification data are shown in the right panel. One of three representative western blot experiments is shown. (H) 0.5 mg/ml actinomycin D was added to DA, respectively solvent, treated Wt BMDMs for 8 h. were normalized for mRNA levels of HPRT (n = 4 independent experiments). Wt BMDMs were stimulated with DA or solvent over a period of 24 h and uptake (K), respectively release (M), of non-transferrin bound iron (NTBI) and transferrin bound iron (TBI) uptake (L) were determined by quantification of 59Fe in a c-counter. Data are shown as means ± SD of four independent experiments and are expressed as percentage of relative iron uptake or release compared with the control (=100%). Values are depicted as lower quartile, median, and upper quartile (boxes) with minimum and maximum ranges. Statistical significant differences as determined by ANOVA using Bonferroni's correction or t-test are indicated. *, P < .05; **, P < .01; ***, P < .001.
Mechanisms underlying transcriptional induction of TfR1 and Fpn1 by dopamine
Our data obtained thus far indicated transcriptional induction of TfR1 and Fpn1 expression and an increase in intracellular iron levels following exposure of BMDMs to DA. Based on the observation that HO-1 and Fpn1 mRNA expression were rapidly induced by DA treatment, we questioned whether such an effect could be mediated by an increase in intracellular iron content by DA and/ or DA mediated oxidative stress. Fig. 2 . Dopamine influences intracellular iron content in macrophages. Wt BMDMs were stimulated with DA or solvent for 6 respectively 24 h. Cellular iron content was measured by atomic absorption spectrometry (A). Results were normalized to protein content. Data from three independent experiments are shown (n = 6-8). Values are depicted as lower quartile, median, and upper quartile (boxes) with minimum and maximum ranges. (B) Western blot analysis of whole cell lysates using specific antibodies to IRP2, ferritin and the loading control b-actin. Western blot bands were quantified densitometrically. For detection of ferritin, 10 mM ferric chloride was added to the DA group as well as to the solvent group. One of three representative western blot experiments is shown. (C) Wt BMDMs were stimulated with DA or solvent for 6 respectively 24 h. The LIP was analyzed by quenching following chelation of low-mass labile iron. Representative blot and quantification (n = 6 per group) of the LIP. BMDMs, isolated from Wt and FTH À/À mice, were treated with DA or solvent for 24 h. Fpn1 (D) and TfR1 (E) expression were determined by qRT-PCR, data were normalized for mRNA levels of HPRT and fold-changes relative to the solvent control were shown (n = 3 independent experiments). BMDMs, isolated from Wt and HO-1 À/À mice, were stimulated with DA or solvent for 24 h. Fpn1 (F) mRNA expression was determined by qRT-PCR, data were normalized for mRNA levels of HPRT (n = 3 independent experiments). Statistical significant differences as determined by ANOVA using Bonferroni's correction or t-test are indicated. Means ± SD; *, P < .05; **, P < .01; ***, P < .001.
Therefore, we studied whether iron chelation by DFO may affect the transcriptional induction of Fpn1 by DA. As shown in Fig. 3A DFO treatment significantly reduced Fpn1 expression by DA but this was still significantly higher than in DFO treated control cells indicating that iron accumulation per se was not solely responsible for DA mediated induction of target genes.
Fpn1 transcription can be induced by the stress sensitive transcription factor Nrf2, which binds to an antioxidative responsive element (ARE) within the Fpn1 promotor [41, 42] . To examine if DA induced Fpn1 transcription via this pathway, we studied Nrf2 expression and Nrf2 binding affinity and found that they were both induced by DA treatment (Fig. 3B, C) . To further confirm these observations, we isolated BMDMs from Wt and Nrf2 À/À mice and exposed them to DA or solvent for 24 h. The DA dependent increase in HO-1 and Fpn1 expression was abolished in Nrf2 À/À BMDMs (Fig. 3D) . Similarly, Fpn1 and HO-1 mRNA induction by DA was abolished or significantly reduced in BMDMs from Nrf2 À/À mice, however, there was still a minor but significant induction of HO-1 mRNA by DA present (Fig. 3E, F) . To examine whether or not Nrf2 activation by DA results from oxidative stress, we measured the concentration of mitochondrial superoxide by using MitoSOX staining (Fig. 3G) . The increased concentration of mitochondrial superoxide due to DA stimulation of Wt BMDMs for 2 h was paralleled by an increased mRNA expression of the stress sensitive enzyme mitochondrial superoxide dismutase (mnSOD) (Fig. 3H) . We further confirmed the driving role of DA-induced oxidative stress for the expression of Fpn1 and HO-1 by using N-acetylcysteine (NAC) as ROS scavenger. NAC treatment of DA stimulated BMDMs resulted in an almost complete blockade of DA-mediated induction of Fpn1 and TfR1 mRNA expression (Fig. 3I, J) . Another redox sensitive transcriptional factor, which is important for HO-1 expression is HIF-1a and its expression was slightly increased even after one hour of DA treatment (Fig. 3K) [43] . Of note, not only HO-1 but also TfR1 transcription is controlled by HIF-1a binding. We hypothesized that this may be the reason for induction of TfR1 transcription in the presence of increased intracellular iron levels. To confirm this, we exposed BMDMs to DA in the presence or absence of PX-12, which decreases HIF-1a activity [44] . Accordingly, the inhibition of HIF-1a activity significantly reduced but not completely abolished DA mediated increase in TfR1 mRNA expression (Fig. 3L) .
Discussion
Here we report that the catecholamine DA, but not tyrosine nor NE, can modify iron homeostasis in macrophages. DA is a neurotransmitter of the catechol family. This neurotransmitter can be produced by the central nervous system, but also by immune cells [45] . During inflammatory stimuli, circulating DA plays an important role as immune regulator [46] . DA can be incorporated into macrophages by DRDs or maybe by widely expressed SLCs [24] [25] [26] . Through the increased accumulation of DA in macrophages, oxidative stress can be induced [28] .
Specifically, we found that DA treatment increased the intracellular iron content of macrophages, which was mainly due to the stimulated uptake of NTBI and reduction in iron export. This finding is consistent with studies in primary cultured astrocytes indicating increased NTBI uptake following stimulation with 6-hydroxydopamine [47] . In addition, we showed that exposure of macrophages to DA resulted in an increased intracellular stress response. The increase in intracellular iron content upon DA treatment resulted in a slightly increased expression of the iron storage protein ferritin and reduced levels of the iron sensitive protein IRP2, which are both indicators of an expansion of the LIP in the cell [1] . This leads to the question of the mechanism underlying cellular iron accumulation by DA. Of note, we found that DA treatment resulted in an increased mRNA expression of TfR1, which did not increase TfR1 mediated iron uptake into cells. The increase in TfR1 mRNA is rather due to an increased TfR1 transcription via stimulation of HIF-1a as a consequence of DA induced oxidative stress [12, 13] . This is reflected by increased HIF-1a stabilization and an abolished effect of DA-dependent TfR1 expression by HIF1a inhibitors. However, the increased TfR1 mRNA expression did not result in comparable induction of TfR1 protein levels nor in stimulation of TfR1 mediated iron uptake, indicating that these processes are regulated by additional factors in this cellular system (for review see [48, 49] ). On the other hand, we found that DA increased the acquisition of NTBI into macrophages. Because the mRNA expression of the NTBI transporters Dmt1 and Zip14 were not significantly altered by DA treatment alternative uptake mechanisms may exist. First, we speculated that DA may complex iron and bind to the siderophore capturing peptide Lcn2, which can shuttle iron across membranes [50] . This possibility was ruled out by using macrophages from Lcn2 À/À mice. Thus, DA may either induce an alternative iron uptake pathway or complex iron in the extracellular environment with subsequent incorporation of DAiron complexes into cells via DRDs or specific solute carriers [51] .
The interaction of iron with DA within the cell likewise promotes oxidative stress via the Fenton reaction, which is confirmed by our data showing increased oxidative stress in mitochondria and increased expression of mitochondrial stress defense enzymes [52] . This intracellular oxidative stress appears to be a major driving force for the increased transcriptional expression of the iron export protein Fpn1 and NAC treatment could almost completely abolish DA-mediated Fpn1 expression. As shown herein, we found that DA induced Nrf2 activation which then promotes the transcription of Fpn1 resulting in increased membrane expression of this protein [31, 41, 42] . Surprisingly, the increased Fpn1 expression was not accompanied by an increased iron export, which rather declined following cellular exposure to DA. We hypothesize that two possible mechanisms may be responsible for this observation. On the one hand, the expansion of the LIP promotes ferritin synthesis and the efficient incorporation of iron into this protein shell making the metal unavailable for cellular iron export. On the other hand, one could speculate that DA-iron complexes persist in the cytoplasm and cannot be transported by Fpn1. In parallel, we also found an increased mRNA expression of HO-1 which also results from DA driven oxidative stress as this effect could be abolished also using a ROS scavenger. An increased HO-1 expression following DA stimulation has been described in cultured glioma cells and primary astrocytes [53] . We showed that this oxidative stress involves activation of Nrf2, because neither significant Fpn1 nor HO-1 mRNA induction by DA could be observed in macrophages from Nrf2 À/À mice. It appears reasonable that the induction of Nrf2 and the subsequent transcription of Fpn1 To analyze the effect of HIF-1a inhibition, Wt BMDMs were stimulated with 10 mM PX-12, a HIF-1a inhibitor, DA or solvent for 24 h. PX-12 was solved in DMSO, therefore an additional solvent group was included. TfR1 expression was determined by qRT-PCR, data were normalized for mRNA levels of HPRT and fold-changes relative to the solvent control were shown (n = 3 independent experiments). Statistically significant differences were calculated by ANOVA using Bonferroni's correction or t-test. Means ± SD; *, P < .05; **, P < .01; ***, P < .001.
and HO-1 are part of cellular responses to limit the detrimental effects of oxidative stress by exporting iron or increasing the availability of radical detoxifying molecules (Fig. 4) . Dysregulation of iron homeostasis in different cellular compartments has been linked to several neurological diseases where DA imbalance plays a central role. Such diseases include PD or restless leg syndrome [54] . Based on the data presented herein, we speculate that there is a direct link between iron homeostasis and DA metabolism, which is not only referred to the fact that iron is an essential cofactor of enzymes like tyrosine hydroxylase. Beyond that, DA appears to affect cellular iron distribution and iron accumulation at least in macrophages. Moreover, dopaminergic drugs may increase cellular iron availability which may underlie the therapeutic efficacy of these drugs in patients with restless leg syndrome, where brain iron deficiency has been discussed [55] . Subsequent studies have to clarify whether DA affects iron homeostasis also in other cells in a comparable fashion, as described herein, and which are the molecular and biophysical details of DA-iron interactions, respectively DA mediated iron shuttling.
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